Tezosentan in Patients With Pulmonary Arterial Hypertension

Update Il y a 4 ans
Reference: NCT01094067

Woman and Man

Extract

Multicenter, double-blind, randomized, placebo-controlled, cross-over study to demonstrate that a single infusion of tezosentan has minimal effect on blood pressure in patients with pulmonary arterial hypertension, treated with endothelin receptor antagonists, phosphodiesterase-5 inhibitors or a combination of both.


Inclusion criteria

  • pulmonary arterial hypertension

Links